Orthogon Therapeutics
Braintree, MA
Orthogon Therapeutics is a preclinical-stage drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets. It focuses on the development of antiviral drugs for immune-suppressed patients.
orthogontherapeutics.comCompany Details
Founded
- 2012
Employees
- Between 2 - 10 employees
Raised
- $23,600,000
Headquarters Location
- Braintree, MA
Public
- No
Acquired
- No
CEO
Ali Munawar
Founders
- Ali Munawar
Company Collections
These are collections Orthogon Therapeutics is a part of. Click on the collection name to view similar companies.
Orthogon Therapeutics' Industries
Orthogon Therapeutics Headquarters Location
1681 Washington St # 2, Braintree, MA 02184
Total Amount Raised: $23,600,000
Orthogon Therapeutics Funding Rounds
Series Unknown
$5,200,000
Series Unknown
$6,000,000
Series B
$8,000,000
Series A
$4,400,000
Series A Investors
Over-the-Rhine VenturesHolbrook Angels of Boston
Funding info provided by Diffbot.
Orthogon Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Orthogon Therapeutics.